Celeb Tattler on MSN
Bhad Bhabie opens up after bad news: God has the final say, not my cancer
Bad news from my doctor yesterday, she wrote, but immediately added a message of hope and faith that has become her trademark ...
A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.
In a community known for stepping up when neighbors are in need, Hatteras Island residents have come together in the past several weeks to support five-year-old Milly King and her […] ...
Canvas Brewing Co., Huntsville, ON The community is coming together on Saturday, March 28th, 2026 for Stand With Sluman, a fundraiser and dance in support of Chris Sluman, a husband, father, and ...
March 5 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's treatment for a type of ...
Acute myeloid leukemia (AML) is a particularly aggressive form of blood cancer that usually progresses rapidly if swift and intensive treatment is not applied. Although the disease can often be ...
Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...
The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism.
A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.
News-Medical.Net on MSN
Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
FDA approves leucovorin for rare disorder, but not for autism after Trump's claims of drug's promise
In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA didn't find evidence of that.
The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results